Home > PS Ratio > BAL PHARMA

BAL PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of BAL PHARMA is 0.67.

Share Price ₹135.9Nov 22,2024
Market Cap ₹216.1 Cr
Sales-TTM₹324.3 CrTTM-Consolidated Results
Price/Sales0.67xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of BAL PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BAL PHARMA is calculated as :

Current Market Cap [ ₹216.1 Cr] as on Nov 22,2024

(/) Sales [ ₹324.3 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 0.67x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BAL PHARMA , the investors are currently willing to pay '0.67 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BAL PHARMA !

The chart below summarizes the trend in P/S Ratio of BAL PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of BAL PHARMA


PS Ratio Performance Analysis for BAL PHARMA

- BAL PHARMA 's latest p/e ratio is 0.67x.

- BAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.39x.

- BAL PHARMA 's operated at median p/e ratio of 0.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2022 at 0.57x.

- BAL PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0.27x.


How does BAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BAL PHARMA 324.30.67216.1
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.57431,352.0
CIPLA LTD26,512.04.53120,035.0
DR REDDYS LABORATORIES LTD30,084.93.37101,286.0
ZYDUS LIFESCIENCES LTD21,483.54.4495,461.4
DIVIS LABORATORIES LTD8,614.018.49159,265.0
MANKIND PHARMA LTD11,018.09.28102,231.0
TORRENT PHARMACEUTICALS LTD11,225.09.56107,306.0
LUPIN LTD21,431.34.4194,430.6
AUROBINDO PHARMA LTD30,295.02.3571,069.8
ABBOTT INDIA LTD6,066.19.7058,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAL PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.67x
Max industry PS 18.49x
Median industry PS 4.53x
Average industry PS 6.85x



You may also like the below Video Courses